Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma.

Lorenzi S, Forloni M, Cifaldi L, Antonucci C, Citti A, Boldrini R, Pezzullo M, Castellano A, Russo V, van der Bruggen P, Giacomini P, Locatelli F, Fruci D.

PLoS One. 2012;7(10):e46928. doi: 10.1371/journal.pone.0046928. Epub 2012 Oct 5.

2.

MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing.

Bao L, Dunham K, Lucas K.

Cancer Immunol Immunother. 2011 Sep;60(9):1299-307. doi: 10.1007/s00262-011-1037-z. Epub 2011 May 28.

PMID:
21626030
3.

NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells.

Forloni M, Albini S, Limongi MZ, Cifaldi L, Boldrini R, Nicotra MR, Giannini G, Natali PG, Giacomini P, Fruci D.

Cancer Res. 2010 Feb 1;70(3):916-24. doi: 10.1158/0008-5472.CAN-09-2582. Epub 2010 Jan 26. Erratum in: Cancer Res. 2010 Apr 1;70(7):2995.

4.

Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes.

Vertuani S, De Geer A, Levitsky V, Kogner P, Kiessling R, Levitskaya J.

Cancer Res. 2003 Nov 15;63(22):8006-13.

5.

Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL.

López-Albaitero A, Nayak JV, Ogino T, Machandia A, Gooding W, DeLeo AB, Ferrone S, Ferris RL.

J Immunol. 2006 Mar 15;176(6):3402-9.

6.

Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.

Meissner M, Whiteside TL, van Kuik-Romein P, Valesky EM, van den Elsen PJ, Kaufmann R, Seliger B.

Br J Dermatol. 2008 May;158(5):930-40. doi: 10.1111/j.1365-2133.2008.08465.x. Epub 2008 Feb 16.

PMID:
18284388
7.

Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.

Ritz U, Momburg F, Pilch H, Huber C, Maeurer MJ, Seliger B.

Int J Oncol. 2001 Dec;19(6):1211-20.

PMID:
11713591
8.

IFN-gamma gene transfer restores HLA-class I expression and MAGE-3 antigen presentation to CTL in HLA-deficient small cell lung cancer.

Traversari C, Meazza R, Coppolecchia M, Basso S, Verrecchia A, van der Bruggen P, Ardizzoni A, Gaggero A, Ferrini S.

Gene Ther. 1997 Oct;4(10):1029-35.

9.

Immune selection in murine tumors. Ph.d thesis.

Svane IM, Engel AM.

APMIS Suppl. 2003;(106):1-46.

PMID:
12739251
10.
11.

Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.

Seliger B, Harders C, Lohmann S, Momburg F, Urlinger S, Tampé R, Huber C.

Eur J Immunol. 1998 Jan;28(1):122-33.

12.

Cytotoxic T lymphocytes induce caspase-dependent and -independent cell death in neuroblastomas in a MHC-nonrestricted fashion.

De Geer A, Kiessling R, Levitsky V, Levitskaya J.

J Immunol. 2006 Dec 1;177(11):7540-50.

13.

HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.

Liu G, Ying H, Zeng G, Wheeler CJ, Black KL, Yu JS.

Cancer Res. 2004 Jul 15;64(14):4980-6.

14.

The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.

Romero I, Martinez M, Garrido C, Collado A, Algarra I, Garrido F, Garcia-Lora AM.

J Pathol. 2012 Jul;227(3):367-79. doi: 10.1002/path.4029. Epub 2012 May 23.

PMID:
22451343
15.

Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.

Wölfl M, Jungbluth AA, Garrido F, Cabrera T, Meyen-Southard S, Spitz R, Ernestus K, Berthold F.

Cancer Immunol Immunother. 2005 Apr;54(4):400-6. Epub 2004 Sep 24.

PMID:
15449039
16.

Characterization of antigen-presenting properties of tumour cells using virus-specific cytotoxic T lymphocytes.

Spierings DC, Agsteribbe E, Wilschut J, Huckriede A.

Br J Cancer. 2000 Apr;82(8):1474-9.

17.

Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens.

Morandi F, Raffaghello L, Bianchi G, Meloni F, Salis A, Millo E, Ferrone S, Barnaba V, Pistoia V.

Stem Cells. 2008 May;26(5):1275-87. doi: 10.1634/stemcells.2007-0878. Epub 2008 Feb 21.

19.

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.

Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR, et al.

Eur J Immunol. 1995 May;25(5):1374-84.

PMID:
7774641
20.

Enhanced expression of interferon-gamma-induced antigen-processing machinery components in a spontaneously occurring cancer.

Cerruti F, Martano M, Petterino C, Bollo E, Morello E, Bruno R, Buracco P, Cascio P.

Neoplasia. 2007 Nov;9(11):960-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk